Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesSelection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activationActivation of RelA homodimers by tumour necrosis factor alpha: a possible transcriptional activator in human vascular endothelial cellsBCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsCloning of the DNA-binding subunit of human nuclear factor kappa B: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alphaDimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.Phosphorylation of ATF-1 enhances its DNA binding and transcription of the Na,K-ATPase alpha 1 subunit gene promoterStructure, function and expression of a murine homeobox protein AREC3, a homologue of Drosophila sine oculis gene product, and implication in developmentTAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulationNF-kappa B contacts DNA by a heterodimer of the p50 and p65 subunitPhysical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptorThe p65 subunit is responsible for the strong transcription activating potential of NF-kappa BThe NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa BReactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1Regulation of the mouse alpha A-crystallin gene: isolation of a cDNA encoding a protein that binds to a cis sequence motif shared with the major histocompatibility complex class I gene and other genesPurification, reconstitution, and I kappa B association of the c-Rel-p65 (RelA) complex, a strong activator of transcriptionNF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeInteractions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genesSpecific NF-kappa B subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcriptionRole of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeatTranscription factor PRDII-BF1 activates human immunodeficiency virus type 1 gene expressionRegulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene productsT cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cellsModulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.Crystal Structure of NFAT Bound to the HIV-1 LTR Tandem κB Enhancer ElementStructural Basis of HIV-1 Activation by NF-κB—A Higher-Order Complex of p50:RelA Bound to the HIV-1 LTRThe Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKRIdentification and expression of six family genes in mouse retinaRegulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa BInvolvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokinesRetroviruses and cancer: models for cancer in animals and humans.Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter.Transcription factors AP-3 and AP-2 interact with the SV40 enhancer in a mutually exclusive manner.Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage.TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors.NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificityRepeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes.
P2860
Q21296830-BCD4C4BE-650D-45DA-8182-236846CB13F2Q24293705-44A6DA5A-C14F-4956-960C-05A9AE6E41ECQ24301448-573F1858-A7C4-4B84-86BE-78A89E07E33FQ24315909-788FE123-07ED-4830-A809-5B1380C40FE9Q24318577-121C1026-15C8-49B3-9BF0-98509774B462Q24321796-71E5EF67-809A-46A9-9B14-BDB99AA6A549Q24522478-D760EDDB-646A-4D30-BDC0-0C9A78A62747Q24544360-67F634AD-20A8-4BDA-B163-73B4351782ABQ24545877-D2A61513-B8A9-40DE-8A86-9C6CD74F9A2EQ24555668-DD79B2EB-3C81-45D3-8BB3-9D58713AA5B2Q24561421-C2FED756-ADED-4930-A0DF-829FBBB9F401Q24561876-5DFDD5C9-BAE3-4FB5-840E-52001884236AQ24564667-DA98ADAE-5A09-447E-9C86-76D47A2CE4ABQ24564833-332A6B85-4366-476D-AA38-EAE1B932FBB0Q24564855-F0C6C187-A9B2-4652-9B60-5648840C9CB8Q24598849-5A175545-3744-4687-BC4E-7AA1F8E0E1DDQ24613327-B1121489-385B-442C-AB89-DBE7E44F91C9Q24629772-B88FE25C-54C8-4B08-880E-EC89596E8FA4Q24630250-11BBE37A-1B88-46EA-9CE2-A059DA268CBEQ24634606-60DB1D14-E66C-46D4-9C28-16211739A83CQ24645001-DD8A44B1-B597-4396-93DC-0AC5E89AE2C1Q24645992-4C6A14C2-83E6-4DE2-8489-C6C185A931BEQ24647749-01A2DDA7-FADD-4730-8015-C54105EC3F7EQ24655654-64D58737-3B26-4979-9C76-ED2538F9665DQ24678251-3225740C-FB91-4566-8E29-A6D9774B8BC1Q24811971-BDAE5290-E9DE-4FB4-AFFF-0FA8B85F5025Q27650549-720C8AA7-97C6-419C-8EFC-521E45C4CD3BQ27657031-9C4B75A2-7CEF-47FA-B8DF-6A67C2A13D75Q28306498-7CE9322C-126F-4D5D-8087-1F89E691F6CBQ28506421-F0FC1B69-A23A-4774-B1B9-CAB7CEA3158CQ28645847-5A06A14B-829A-4DCB-8281-1CD49714F6CEQ28646316-4A7842EF-65D0-40DD-90D7-E73F8860C47DQ30467457-47219B32-F90C-41EC-AB97-D1C01025A8CCQ33562993-229805B7-9E33-4410-832B-3D711E7DB1F0Q33565063-89EBFA91-1E62-4657-B990-985D2466C285Q33587139-B97E091D-431E-46A7-BA11-6E2522300952Q33609443-6C870AE2-FB0F-473B-830F-73BBB41F487EQ33676218-599A933A-6999-4BFE-AD6C-AEDAFE07C943Q33684251-D24948AF-D155-4761-8484-32382C6DBF9FQ33847436-C0656531-17DA-454B-AF41-8C402EE01B80
P2860
Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro
description
1988 nî lūn-bûn
@nan
1988 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Identification and purificatio ...... virus type 1 promoter in vitro
@ast
Identification and purificatio ...... virus type 1 promoter in vitro
@en
Identification and purification of a human immunoglobulin-enhancer-binding protein
@nl
type
label
Identification and purificatio ...... virus type 1 promoter in vitro
@ast
Identification and purificatio ...... virus type 1 promoter in vitro
@en
Identification and purification of a human immunoglobulin-enhancer-binding protein
@nl
prefLabel
Identification and purificatio ...... virus type 1 promoter in vitro
@ast
Identification and purificatio ...... virus type 1 promoter in vitro
@en
Identification and purification of a human immunoglobulin-enhancer-binding protein
@nl
P2093
P2860
P356
P1476
Identification and purificatio ...... virus type 1 promoter in vitro
@en
P2093
C Scheidereit
K Kawakami
R G Roeder
P2860
P304
P356
10.1073/PNAS.85.13.4700
P407
P577
1988-07-01T00:00:00Z